Business / Finance

RSS

Bioton and Actavis form joint venture

Actavis and Bioton announced today that they have formed a joint venture company for the development and registration of insulins, including analogue insulins.

31 Jan 2012

Indoco, DSM sign agreement for commercial cooperation for eight APIs

Royal DSM N.V., today announced the signing of an agreement with Indoco Remedies Limited, Mumbai, India, for commercial cooperation for eight Active Pharmaceutical Ingredients (APIs). The alliance came into effect in January 2012.

31 Jan 2012

Acadia selects HMS financial-management applications and modules

Acadia Healthcare Company, Inc. has chosen a suite of fully integrated financial-management applications from Healthcare Management Systems Inc. (HMS) to help maximize the operating efficiency of more than two dozen of its facilities nationwide.

31 Jan 2012

Springbrook to purchase St. Mary's School property

Springbrook, a leader in providing innovative supports for people with developmental disabilities, today announced the planned purchase of the St. Mary's School property located on state highway 7 in Oneonta, New York.

31 Jan 2012

Hologic first quarter revenues increase 9.3% to $472.7 million

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced its results for the first fiscal quarter ended December 24, 2011.

From Hologic, Inc. 31 Jan 2012

China Botanic fourth quarter net revenue increases 12.8% to $18.8M

China Botanic Pharmaceutical Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and Traditional Chinese Medicines in China, today announced financial results for the three months and fiscal year ended October 31, 2011.

31 Jan 2012

Array second quarter revenue increases to $23.2 million

Array BioPharma Inc. today reported financial results for the second quarter of fiscal 2012.

31 Jan 2012

McKesson third quarter revenues increase 9% to $30.8 billion

McKesson Corporation today reported that revenues for the third quarter ended December 31, 2011 were up 9% to $30.8 billion compared to $28.2 billion a year ago. On the basis of U.S. generally accepted accounting principles, third-quarter earnings per diluted share was $1.20 compared to $0.60 a year ago.

30 Jan 2012

ConforMIS raises $89M in Series E round of funding

Surpassing all previous fundraising rounds, privately-held medical device company ConforMIS, Inc. announced today that it has raised $89 million in a Series E round of funding, with additional funds beyond this amount committed upon meeting certain milestones.

30 Jan 2012

Valeant withdraws ISTA acquisition offer

Valeant Pharmaceuticals International, Inc. today announced that it has withdrawn its offer to acquire ISTA Pharmaceuticals Inc. for $7.50 per share in cash.

30 Jan 2012

FTC terms Omnicare's proposed acquisition of PharMerica illegal

The Federal Trade Commission issued a complaint to block Omnicare, Inc.'s hostile acquisition of rival long-term care pharmacy provider PharMerica Corporation, alleging that the combination of the two largest U.S. long-term care pharmacies would harm competition and enable Omnicare to raise the price of drugs for Medicare Part D consumers and others.

30 Jan 2012

Proposed Express Scripts-Medco merger endangers over 2,400 jobs in New Jersey

New Jersey would lose over 2,400 jobs, local economies would suffer and patients may be denied their choice of pharmacy if the proposed mega-merger of two prescription drug middlemen goes through, the National Community Pharmacists Association (NCPA) said today.

30 Jan 2012

Checkpoint Surgical completes $1.7M Series B investment round

Neurodevice firm Checkpoint Surgical completed a $1.7 million Series B investment round led by the NDI Healthcare Fund in December 2011, and secured non-dilutive funding of over $1.3 million, including a $1.065 million Innovation Ohio loan and a $245,000 federal grant.

30 Jan 2012

Bionovo announces voluntary decision to delist from NASDAQ

Bionovo, Inc., today announced that on January 26, 2012, its Board of Directors decided to seek a voluntary delisting from the NASDAQ Capital Market.

30 Jan 2012

Medtronic signs exclusive distribution agreement with Miami Instruments

Medtronic, Inc. today announced that it has entered into an exclusive distribution agreement with Miami Instruments, LLC - a company focused on the design of innovative surgical instruments for minimally invasive cardiac surgery procedures - and has introduced the company's first two products in the U.S.

From Medtronic 30 Jan 2012

IDEXX fourth quarter revenues increase 8% to $307.2 million

IDEXX Laboratories, Inc., today reported that revenues for the fourth quarter of 2011 increased 8% to $307.2 million, from $283.8 million for the fourth quarter of 2010. Organic revenue growth, as defined below, was 7%. Earnings per diluted share ("EPS") for the quarter ended December 31, 2011 increased 8% to $0.67, compared to $0.62 for the same period in the prior year.

27 Jan 2012

Amgen enters definitive merger agreement to acquire Micromet

Amgen and Micromet, Inc. today announced that the companies have entered into a definitive merger agreement under which Amgen will acquire Micromet, a biotechnology company founded in Germany with its research and development (R&D) center in Munich and headquarters in Rockville, Md., for $11 per share in cash.

27 Jan 2012

drchrono closes $2.8 million round of funding

drchrono, the company that is transforming the focus of healthcare from the enterprise to the provider, today announced it has closed a $2.8 million round of funding led by Yuri Milner and featuring new investors that share a legacy of innovation and business transformation.

27 Jan 2012

Celgene signs definitive merger agreement to acquire Avila

Celgene Corporation and Avila Therapeutics, Inc., a privately held biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, today announced a definitive merger agreement under which Celgene Corporation will acquire Avila Therapeutics, Inc.

26 Jan 2012